KDR and breast cancer: Similarly, mice treatment with DC101 (a rat monoclonal antibody directed against mouse VEGFR2), in addition to suppressing BC growth, attenuates the MDSCs’ inhibitory effect on T cells and reduces the number of Tregs in both primary BCs and lung metastases of BC [127].